Route of administration of contrast media into the uterus
(57) Abstract:The invention relates to medicine and can be used for injection of contrast media into the uterus. Conduct x-ray examination, in which the uterine cavity is placed a double elastic spray conduit, through which when applying the radiopaque substance is filling the first container in the form of a balloon and the second balloon, which hugs and contrasts the surface of the tumor. The method improves the accuracy of intraoral diagnosis of malignant processes of the body of the uterus and prevent tumour metastasis, as well as the penetration of other pathological cells through the vessels and the natural passages in other parts of the uterus. The invention relates to medicine, namely to x-ray research in Oncology, and can be used in gynecology when performing fluoroscopy hollow organs in the presence of a pathologic focus.It is known that intracavitary diagnostics of malignancies of the body of the uterus is associated with serious technical difficulties and hazards (Rusin J. I. Contrast radiography in gynecology. - M.: Medgiz, 1959, S. 60-70). Actually the target into the cavity of the pipe and further into the abdominal cavity, but accordingly accompanied by the spread in the same direction tumor cells from the primary lesion.When all these costs are almost impossible to determine the amount of the residual cavity of the uterus, as well as the size and shape of the tumor. It should be noted that changing the volume of the uterine cavity in the direction of decreasing indirectly confirms the progression of the process, and the increase - about the effectiveness of any treatment method.Known "Method of filling hollow bodies athenacentral substance" (ed. mon. 1009474, from 07.04.83. Bull. 13, ed. Y. S. Sidorenko, A. K. Pankow, F. M. Stein), involving the introduction of a radiopaque substance into the test cavity is chosen as a prototype. The essence of the method is that for the purpose of preventing the dissemination of the contents of the nidus, prior to the introduction of a radiopaque substance into the hollow body is placed an elastic bag which is injected radio-opaque substance to fill the entire cavity of the hollow body of elastic bag.Thus, the use of this method allows to avoid the contrast medium in the pipe, and with him and tumor cells. In addition to the government, that it is impossible to define the contours of tumors of the uterine cavity. In fact, during the filling of the flexible bag he always tends to take the form of a sphere, so its surface he can only compress the tumor, but does not fit her, passing her contours.The aim of the invention is the determination of the contours and volume of tumors of body of uterus during the initial radiological investigation and treatment stages.This goal is achieved by the fact that when conducting x-ray examinations of the uterine cavity prior to the introduction of contrast medium into the uterine cavity placed double elastic spray conduit, through the conduit injected radiopaque substance, fill the first container in the form of a sphere, then the second canister that fits and contrasts the surface of the tumor.The invention "Method of injection of contrast media into the uterus" is new, because it is unknown the level of medicine in the field of introduction of contrast agents in x-ray hollow organs in the presence of a pathologic focus.The novelty of the invention lies in the fact that prior to the introduction of contrast medium into the uterine cavity placed double elastic BA is the first canister, who hugs and contrasts the surface of the tumor.The invention involves an inventive step, as a physician-oncologist, radiologist, it is unknown under fluoroscopy hollow organs in gynecology in the presence of a pathologic focus.Known methods of radiological examination of the uterus accompanied by ingestion of contrast material into the cavity of the pipe and then into the abdominal cavity, the spread of tumor cells from the primary lesion. It is almost impossible to determine the residual volume of the uterine cavity, are not covered by the tumor, the change of volume during treatment.Thus, the proposed technical solution is not obvious, has distinctive characteristics, is not clear from the level of development of Oncology in the field of x-ray examinations in Oncology, it is not known neither in the world nor in the Russian and CIS medical literature.The invention is industrially applicable as it can be used in health care for radiological research in Oncology, gynecology, cancer research institutes, oncologic dispensaries and protracted funds in the uterus" is as follows.In a hollow organ such as the uterus, enter the device is a hollow rigid conductor, rounded on the end inserted into the uterus, and is equipped with side holes for expiration in the uterus of contrast agents. On the rounded end of the conductor is wearing a double elastic balloon, the neck of the balloon is fixed to the conductor below the holes. The device is introduced into the body before contact of the conductor with the fundus of the uterus. Then double elastic balloon serves a radiopaque substance. When filling the first balloon inflated balloon fills the free space of the uterine cavity. When completing the second spray it adheres to the surface of the tumor. After that produce x-rays. On radiographs easily detect filling defects in the presence of a tumor in the body of the uterus. Tumor of the uterus fits the second elastic balloon, contrasts the contours of the surface of the tumor on the x-ray.Technical and economic efficiency "as a way of introduction of contrast media into the uterus" is that the application of the method allows abdominal x-ray examination provides an objective and accurate vnutripolostno the residual cavity of the uterus decrease in the progression of the process, while increasing the effectiveness of treatment. Furthermore, the method prevents tumour metastasis or infiltration of other abnormal cells through the vessels and the natural passages in other parts of the uterus. Route of administration of contrast media into the uterus, including rentgenologicheski study, characterized in that the uterine cavity is placed a double elastic spray conduit, through which, when applying a radiopaque substance, is the filling of the first container in the form of a balloon and the second balloon, which hugs and contrasts the surface of the tumor.
SUBSTANCE: method involves carrying out X-ray examination with radiopaque substance being used. Biologically inert flexible cups for porolon inlay to be placed congruently to gingiva contour. The inlay is impregnated with Dimexid and left in oral cavity for 30-40 min before making X-ray examination.
EFFECT: high accuracy of diagnosis.
FIELD: medicine, radiology, pharmacy.
SUBSTANCE: invention relates to an agent used in contrasting in carrying out the diagnostic radiology that comprises tantalite of at least one element taken among the group including yttrium, lanthanum, cerium, praseodymium, neodymium, samarium, europium, gadolinium, terbium, holmium, erbium, thulium, ytterbium, lutecium or bismuth, organic additive and water wherein the natural polysaccharide with acid functional groups is used as an organic additive in the definite ratio of components. Invention provides preparing an agent exhibiting uniform distribution of insoluble particles, high effectiveness of absorption in the low dose given to a patient, and high degree of contrasting, the combination of high adhesion to mucosa tissue of organs and good fluidity in applying the external stress that results to increasing reliability of results in carrying out the diagnosis. Invention can be used as X-ray contrast agent in X-ray assay of different organs.
EFFECT: valuable properties of agent.
3 cl, 9 ex
FIELD: veterinary science.
SUBSTANCE: the present innovation deals with performing anesthesia, slow injection of roentgenocontrast preparation as trasograph pre-diluted with water for 50% with the help of catheter into trachea at the quantity of 10% against poultry body weight, and roentgenoscopy to be carried out 10 min after injection, not later. The innovation provides the chance to study thoracic air sacs without lancing for putting postmortem diagnosis and for research objectives.
EFFECT: higher efficiency of studying.
SUBSTANCE: method involves introducing a mixture into purulent cavities or fistula path. The mixture contains 10 ml of 76% Urografin alcohol solution and 2 ml of 1% brilliant green alcohol solution to enable one to carry out following visual and X-ray estimation of surgical treatment quality.
EFFECT: objective estimation of bone and soft tissue volume and injury degree.
FIELD: pharmaceutical industry, in particular medicine X-ray contrast diagnosis agent.
SUBSTANCE: claimed pellet-shaped agent contains oxymethyl uracil, barium sulfate for fluoroscopy and potato starch in ratio of 4:1 or 6:1, wherein corn is coated with 5 % alcohol/acetone acetylphthalylcellulose solution, 10 % low molecular polyethylene solution in hexane and medical adhesive. Agent of present invention provides disintegration ability of active ingredient in intestine for 2, 4, 6 hours.
EFFECT: system for intestinal diagnosis with treating action, improved convenience and sanitary effect.
FIELD: medicine, gastroenterology.
SUBSTANCE: one should study motor-evacuation activity of gastroduodenal transition, carry out ultrasound investigation including the introduction of a contrast followed by scanning a longitudinal section of antroduodenal area. On registering the onset of contrast evacuation out of stomach into the upper-horizontal duodenal part one should start counting the number of peristaltic waves in antral gastric department for 180 sec, then a pick-up unit should be replaced under the lower hepatic edge into projection area of the upper-horizontal duodenal part to count the number of peristaltic waves in duodenum during 180 sec at subsequent detection of the coefficient for antroduodenal coordination by the following formula: C=Pa/Pd, where C - coefficient of antroduodenal coordination, Pa - the number of peristaltic waves in antral gastric department, Pd - the number of peristaltic waves in duodenum, and at coefficient value of antroduodenal coordination being 0.25-0.33 one should detect the norm, at the value being above 0.33 one should detect hypokinetic variant of disorders in antroduodenal coordination and at the value being below 0.25 it is possible to detect hyperkinetic variant of disorders in antroduodenal coordination.
EFFECT: higher efficiency for differential diagnostics.
SUBSTANCE: method involves carrying out irrigoscopy examination under artificial hypotonia of large intestine with single-stage double opacification of large intestine done with fine peptized aqueous barium cocktail heated to 36°C composed of water - 100 ml, sodium citrate - 1.5 g, sugar - 8 g, barium sulfate - 200 g, carboxymethyl cellulose 0.5 g, raw hen eggs - 2 eggs. Irrigoscopy examination is repeatedly carried out in 24 h. Ribbon-like shadows being observed, intestinal heminthiasis is to be diagnosed.
EFFECT: high reliability in determining shape and localization of helminth even in the cases of negative coprological and serological examination results.
FIELD: medicine, oncology.
SUBSTANCE: one should detect the value of available radionuclides 59Fe in diagnosed area of mammary glands, moreover, in case when one mammary gland is healthy at detecting the presence of nodes one should apply the difference in the values of available radionuclides in right- and left-hand mammary glands to be compared with threshold value; in case of the disease in both mammary glands, or in case when one gland is after operation one should detect the availability of nodes according to the value of available radionuclides 59Fe in right- and left-hand mammary glands to be compared with a standard value; and in case of excessive values - either threshold or standard ones, correspondingly, the state of diagnosed area should be evaluated as pathology, in case of pathology one should treat this area with preparation indinol at the content of indole-3-carbinol being up to 98% of pure weight at the dosage of about 350-500 mg daily; then, 25-35 d later one should repeat the same testing and if the mentioned difference of the value of available radionuclides exceeds either a threshold or the standard value, correspondingly, one should continue therapy course till the next inspection, and, in such a way till the moment when the mentioned difference should be equal or less against the preset threshold or standard value, correspondingly, or, when total therapy course doesn't exceed the preset time interval. The present innovation enables to detect small-sized nodes being of 5 mm size.
EFFECT: higher accuracy and efficiency of diagnostics.
3 cl, 2 ex
FIELD: medicine, radionuclide diagnostics, cardiology, cardiosurgery.
SUBSTANCE: the present innovation deals with carrying out radionuclide angiopulmonography in rest and at the background of pharmacological tests with peripheral vasodilators. Moreover, as a radiopharmpreparation it is possible to apply 99mTc-diethylene triaminopentaacetate. One should successively conduct the series of pharmacological tests at intravenous form of enalaprilate and sublingual form of nifedipin. At increase value of blood shunting at the background of enalaprilate case being >0.1 against the initial one and modal arterial time at the background of nifedipin case being >10% one should predict the flow of pulmonary hypertension to be favorable, and at simultaneous absence of alterations in these values against their initial data the prediction is considered to be unfavorable.
EFFECT: higher accuracy of prediction.
2 dwg, 2 ex, 2 tbl
FIELD: medicine, oncology.
SUBSTANCE: one should carry out pervaginal visceral phlebography and after detecting with it specific vascular symptomocomplexes that characterize sarcomatous myometrial degeneration it is necessary to perform puncture myometrial biopsy transvaginally with a thick needle in the site of projection of the supposed tumor - beyond the bottom. The innovation enables to differentiate uterine sarcoma against fibromatous nodes and prove morphological belonging of malignant tumor.
EFFECT: higher efficiency of diagnostics.
2 dwg, 2 ex